{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:57:12Z","timestamp":1790704632148,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jacc.2022.06.037","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T08:35:07Z","timestamp":1661762107000},"page":"1130-1143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["Sacubitril\/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7380-4144","authenticated-orcid":false,"given":"Jawad H.","family":"Butt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Dewan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pardeep S.","family":"Jhund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inder S.","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Atar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay S.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis E.","family":"Echeverria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"K\u00f8ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.P.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2764-6779","authenticated-orcid":false,"given":"Aldo P.","family":"Maggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton","family":"Packer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean L.","family":"Rouleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk J.","family":"Van Veldhuisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojan","family":"Vrtovec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Zile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjian","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P.","family":"Lefkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel R.","family":"Rizkala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6317-3975","authenticated-orcid":false,"given":"John J.V.","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2022.06.037_bib1","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jacc.2022.06.037_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/gerona\/59.3.M255","article-title":"Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care","volume":"59","author":"Fried","year":"2004","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jacc.2022.06.037_bib3","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(19)31786-6","article-title":"Frailty: implications for clinical practice and public health","volume":"394","author":"Hoogendijk","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2022.06.037_bib4","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people","volume":"381","author":"Clegg","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2022.06.037_bib5","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.ahj.2013.07.032","article-title":"Frailty and risk for heart failure in older adults: the Health, Aging, and Body Composition Study","volume":"166","author":"Khan","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2022.06.037_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijcard.2017.01.153","article-title":"The prevalence of frailty in heart failure: a systematic review and meta-analysis","volume":"236","author":"Denfeld","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2022.06.037_bib7","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/ejhf.2011","article-title":"Cachexia, muscle wasting, and frailty in cardiovascular disease","volume":"22","author":"Bielecka-Dabrowa","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2022.06.037_bib8","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/ejhf.1611","article-title":"Heart\u00a0Failure Association\/European Society of Cardiology position paper on frailty in patients with heart failure","volume":"21","author":"Vitale","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2022.06.037_bib9","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1111\/jgs.15141","article-title":"Evolution of a geriatric syndrome: pathophysiology and treatment of heart failure with preserved ejection fraction","volume":"65","author":"Upadhya","year":"2017","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jacc.2022.06.037_bib10","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/ejhf.1832","article-title":"The prevalence and importance of frailty in heart failure with reduced ejection fraction\u2014an analysis of PARADIGM-HF and ATMOSPHERE","volume":"22","author":"Dewan","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2022.06.037_bib11","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/ejhf.1308","article-title":"The frailty syndrome and outcomes in the TOPCAT trial","volume":"20","author":"Sanders","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2022.06.037_bib12","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jamda.2018.06.009","article-title":"Frailty and clinical outcomes in heart failure: a systematic review and meta-analysis","volume":"19","author":"Zhang","year":"2018","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jacc.2022.06.037_bib13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/ageing\/afy194","article-title":"Frailty and co-morbidity predict first hospitalisation after heart failure diagnosis in primary care: population-based observational study in England","volume":"48","author":"Bottle","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.jacc.2022.06.037_bib14","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ejhf.518","article-title":"Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with\u00a0heart failure","volume":"18","author":"Vid\u00e1n","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2022.06.037_bib15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF Registry","volume":"72","author":"Greene","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.06.037_bib16","first-page":"13","article-title":"Contemporary drug treatment of chronic heart failure with reduced ejection fraction: the CHECK-HF Registry","volume":"7","author":"Brunner-La Rocca","year":"2019","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2022.06.037_bib17","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1177\/2047487319835042","article-title":"Age differences in contemporary treatment of patients with chronic heart failure and reduced ejection fraction","volume":"26","author":"Veenis","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2022.06.037_bib18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00228-018-2598-y","article-title":"Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases","volume":"75","author":"Curtin","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2022.06.037_bib19","first-page":"1523","article-title":"Utility of frailty assessment for elderly patients undergoing cardiac resynchronization therapy","volume":"3","author":"Kubala","year":"2017","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2022.06.037_bib20","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2459\/JCM.0b013e328339d981","article-title":"Usefulness of frailty profile for targeting older heart failure patients in disease management programs: a cost-effectiveness, pilot study","volume":"11","author":"Pulignano","year":"2010","journal-title":"J\u00a0Cardiovasc Med"},{"key":"10.1016\/j.jacc.2022.06.037_bib21","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin\u2013neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.06.037_bib22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1100\/tsw.2001.58","article-title":"Accumulation of deficits as a proxy measure of aging","volume":"1","author":"Mitnitski","year":"2001","journal-title":"Scientific World J"},{"key":"10.1016\/j.jacc.2022.06.037_bib23","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/gerona\/62.7.722","article-title":"Frailty in relation to the accumulation of deficits","volume":"62","author":"Rockwood","year":"2007","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jacc.2022.06.037_bib24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2318-8-24","article-title":"A\u00a0standard procedure for creating a frailty index","volume":"8","author":"Searle","year":"2008","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jacc.2022.06.037_bib25","first-page":"471","article-title":"Angiotensin receptor neprilysin inhibition in heart failure with preserved ejection fraction: rationale and design of the PARAGON-HF trial","volume":"5","author":"Solomon","year":"2017","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2022.06.037_bib26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s11357-017-9993-7","article-title":"A\u00a0frailty index from common clinical and laboratory tests predicts increased risk of death across the life course","volume":"39","author":"Blodgett","year":"2017","journal-title":"GeroScience"},{"key":"10.1016\/j.jacc.2022.06.037_bib27","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.archger.2015.01.016","article-title":"Frailty in NHANES: comparing the frailty index and phenotype","volume":"60","author":"Blodgett","year":"2015","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.jacc.2022.06.037_bib28","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/gerona\/gly094","article-title":"A\u00a0Frailty Index for UK Biobank participants","volume":"74","author":"Williams","year":"2019","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jacc.2022.06.037_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/gerona\/glab225","article-title":"Validation of a deficit-accumulation frailty index in the ASPirin in Reducing Events in the Elderly Study and its predictive capacity for disability-free survival","volume":"77","author":"Ryan","year":"2022","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jacc.2022.06.037_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/gerona\/glu089","article-title":"Frailty in the Honolulu-Asia aging study: deficit accumulation in a male cohort followed to 90% mortality","volume":"70","author":"Armstrong","year":"2015","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jacc.2022.06.037_bib31","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s40520-016-0689-0","article-title":"Development and validation of a frailty index in the Longitudinal Aging Study Amsterdam","volume":"29","author":"Hoogendijk","year":"2017","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jacc.2022.06.037_bib32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12916-015-0328-1","article-title":"No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo","volume":"13","author":"Warwick","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.jacc.2022.06.037_bib33","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/gerona\/glv228","article-title":"Characterizing frailty status in the Systolic Blood Pressure Intervention Trial","volume":"71","author":"Pajewski","year":"2016","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jacc.2022.06.037_bib34","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/gerona\/glt183","article-title":"Plasma protein biomarkers of the geriatric syndrome of frailty","volume":"69","author":"Darvin","year":"2014","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jacc.2022.06.037_bib35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2022.06.037_bib36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/eurjhf\/hfn037","article-title":"The cyclic guanosine monophosphate\/B-type natriuretic peptide ratio and mortality in advanced heart failure","volume":"11","author":"Louren\u00e7o","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2022.06.037_bib37","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.06.037_bib38","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/ijcp.12313","article-title":"Comprehensive geriatric assessment\u2014a guide for the non-specialist","volume":"68","author":"Welsh","year":"2014","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jacc.2022.06.037_bib39","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.3346\/jkms.2020.35.e16","article-title":"Frailty and comprehensive geriatric assessment","volume":"35","author":"Lee","year":"2020","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.jacc.2022.06.037_bib40","first-page":"1001","article-title":"Frailty is intertwined with heart failure: mechanisms, prevalence, prognosis, assessment, and management","volume":"7","author":"Pandey","year":"2019","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2022.06.037_bib41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa2026141","article-title":"Physical rehabilitation for older patients hospitalized for heart failure","volume":"385","author":"Kitzman","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.06.037_bib42","article-title":"Trends in frailty and use of evidence-based pharmacotherapy for heart failure in Australian hospitalised patients: an observational study","volume":"10","author":"Sharma","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jacc.2022.06.037_bib43","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.2337\/dc20-2664","article-title":"The impact of frailty on the effectiveness and safety of intensive glucose control and blood pressure-lowering therapy for people with type 2 diabetes: results from the ADVANCE trial","volume":"44","author":"Nguyen","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2022.06.037_bib44","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7326\/M21-4776","article-title":"Efficacy and safety of dapagliflozin according to frailty in heart failure with reduced ejection fraction: a post hoc analysis of the DAPA-HF trial","volume":"175","author":"Butt","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2022.06.037_bib45","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(19)31785-4","article-title":"Management of frailty: opportunities, challenges, and future directions","volume":"394","author":"Dent","year":"2019","journal-title":"Lancet"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109722055966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109722055966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:51:14Z","timestamp":1760017874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109722055966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0735109722055966"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2022.06.037","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sacubitril\/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2022.06.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}